Regulation FD Disclosure

Business Context and Reporting Period

Company: National Healthcare Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 28, 2025
Principal Executive Offices: 540 Madison Ave, 27th Floor, New York, NY 10022
Securities Registered: 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NHPAP) and 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (NHPBP) on The Nasdaq Global Market.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure notice regarding the availability of an investor presentation rather than a financial statement containing detailed metrics.

Material Changes

No material changes to financial performance or portfolio composition are detailed within the text of this filing. The document solely announces the preparation and distribution of an investor presentation containing portfolio information and financial highlights.

Guidance, Outlook, and Management Commentary

  • Regulation FD Disclosure: The Company prepared an investor presentation with portfolio information and financial highlights.
  • Distribution Plan: Representatives intend to present this material to current investors and financial advisors at various conferences, meetings, and webinars.
  • Availability: The presentation is furnished as Exhibit 99.1 and is available on the Company's website (www.nhpreit.com).
  • Legal Status: The information in this 8-K and Exhibit 99.1 is "furnished" and not "filed" under the Exchange Act. It is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Review Exhibit 99.1 (Investor Presentation) for specific portfolio data and financial highlights not included in this summary.
  • Verify the content of the investor presentation on the Company's official website.
  • Confirm the status of the 7.375% Series A and 7.125% Series B Preferred Stock on The Nasdaq Global Market.
  • Note that the financial data in the presentation is not legally "filed" with the SEC for liability purposes under Section 18 of the Exchange Act.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.